Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Influenza, Human"" wg kryterium: Temat


Tytuł:
Covid-19 and influenza vaccine effectiveness against associated hospital admission and death among individuals over 65 years in Norway: A population-based cohort study, 3 October 2022 to 20 June 2023.
Autorzy:
Seppälä E; Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
Dahl J; Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
Veneti L; Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway.
Rydland KM; Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
Klüwer B; Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
Rohringer A; Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.
Meijerink H; Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway. Electronic address: .
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2024 Jan 25; Vol. 42 (3), pp. 620-628. Date of Electronic Publication: 2023 Dec 23.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza Vaccines*
COVID-19*/epidemiology
COVID-19*/prevention & control
Humans ; Aged ; COVID-19 Vaccines ; Cohort Studies ; Vaccine Efficacy ; SARS-CoV-2 ; Norway/epidemiology ; Hospitalization ; Hospitals
Czasopismo naukowe
Tytuł:
Cardiologists' knowledge and perceptions of the seasonal influenza immunisation.
Autorzy:
Monagle SR; Monash Heart, Monash Health, Victoria, Australia; Victorian Heart Institute, Monash University, Clayton, Australia.
Spear E; Monash Heart, Monash Health, Victoria, Australia; Victorian Heart Institute, Monash University, Clayton, Australia.
Abrahams T; Monash Heart, Monash Health, Victoria, Australia; Victorian Heart Institute, Monash University, Clayton, Australia.
Thakur U; Monash Heart, Monash Health, Victoria, Australia; Victorian Heart Institute, Monash University, Clayton, Australia.
Pol D; Monash Heart, Monash Health, Victoria, Australia; Victorian Heart Institute, Monash University, Clayton, Australia.
Tan S; Monash Heart, Monash Health, Victoria, Australia; Victorian Heart Institute, Monash University, Clayton, Australia.
Bellamy K; Monash Health Infectious Diseases, Clayton, Australia.
Hickman J; Monash Health Infectious Diseases, Clayton, Australia.
Jackson B; Monash Heart, Monash Health, Victoria, Australia; Victorian Heart Institute, Monash University, Clayton, Australia.
Chan J; Monash Heart, Monash Health, Victoria, Australia; Victorian Heart Institute, Monash University, Clayton, Australia.
Nicholls SJ; Monash Heart, Monash Health, Victoria, Australia; Victorian Heart Institute, Monash University, Clayton, Australia.
Nelson AJ; Monash Heart, Monash Health, Victoria, Australia; Victorian Heart Institute, Monash University, Clayton, Australia. Electronic address: .
Pokaż więcej
Źródło:
International journal of cardiology [Int J Cardiol] 2024 Mar 15; Vol. 399, pp. 131654. Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:
Journal Article
MeSH Terms:
Cardiologists*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Heart Diseases*
Humans ; Seasons ; Surveys and Questionnaires ; Immunization
Czasopismo naukowe
Tytuł:
Influenza vaccination before and during the COVID-19 pandemic in the elderly in South Korea.
Autorzy:
Kim DJ; Department of Preventive Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Public Health, Graduate School, The Catholic University of Korea, Seoul, Republic of Korea.
Cho KH; Department of Health Policy and Management, Sangji University, Wonju, Gangwon-do, Republic of Korea.
Kim S; Department of Preventive Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Public Health and healthcare management, Graduate School, The Catholic University of Korea, Seoul, Republic of Korea.
Lee H; Department of Preventive Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Public Health, Graduate School, The Catholic University of Korea, Seoul, Republic of Korea; Department of Public Health and healthcare management, Graduate School, The Catholic University of Korea, Seoul, Republic of Korea. Electronic address: .
Pokaż więcej
Źródło:
Journal of infection and public health [J Infect Public Health] 2024 Mar; Vol. 17 (3), pp. 503-508. Date of Electronic Publication: 2023 Dec 06.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza Vaccines*
Humans ; Aged ; Pandemics ; Vaccination ; Republic of Korea/epidemiology ; Seasons
Czasopismo naukowe
Tytuł:
Effects of scheduled school breaks on the circulation of influenza in children, school-aged population, and adults in China: A spatio-temporal analysis.
Autorzy:
Qiao M; Department of Biostatistics, National Vaccine Innovation Platform, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
Zhu F; Department of Biostatistics, National Vaccine Innovation Platform, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
Chen J; Department of Biostatistics, National Vaccine Innovation Platform, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
Li Y; Department of Epidemiology, National Vaccine Innovation Platform, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China; Usher Institute, The University of Edinburgh, Edinburgh, United Kingdom.
Wang X; Department of Biostatistics, National Vaccine Innovation Platform, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China; Usher Institute, The University of Edinburgh, Edinburgh, United Kingdom. Electronic address: .
Pokaż więcej
Źródło:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Mar; Vol. 140, pp. 78-85. Date of Electronic Publication: 2024 Jan 11.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Epidemics*
Child ; Adult ; Humans ; Child, Preschool ; China/epidemiology ; Schools ; Spatio-Temporal Analysis
Czasopismo naukowe
Tytuł:
Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study.
Autorzy:
Xie Y; Clinical Epidemiology Center, Research and Development Service, VA Saint Louis Health Care System, Saint Louis, MO, USA; Veterans Research and Education Foundation of Saint Louis, Saint Louis, MO, USA; Division of Pharmacoepidemiology, Clinical Epidemiology Center, Research and Development Service, VA Saint Louis Health Care System, Saint Louis, MO, USA.
Choi T; Clinical Epidemiology Center, Research and Development Service, VA Saint Louis Health Care System, Saint Louis, MO, USA; Veterans Research and Education Foundation of Saint Louis, Saint Louis, MO, USA.
Al-Aly Z; Clinical Epidemiology Center, Research and Development Service, VA Saint Louis Health Care System, Saint Louis, MO, USA; Veterans Research and Education Foundation of Saint Louis, Saint Louis, MO, USA; Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA; Nephrology Section, Medicine Service, VA Saint Louis Health Care System, Saint Louis, MO, USA; Institute for Public Health, Washington University in Saint Louis, Saint Louis, MO, USA. Electronic address: .
Pokaż więcej
Źródło:
The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Mar; Vol. 24 (3), pp. 239-255. Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Humans ; Cohort Studies ; Seasons ; SARS-CoV-2 ; Hospitals
Czasopismo naukowe
Tytuł:
Adequate immune responses to vaccines after chemotherapy for leukaemia diagnosed in childhood.
Autorzy:
Óskarsson Ý; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
Thors V; The Children's Hospital Iceland, Landspítali University Hospital, Reykjavík, Iceland.; Department of Medicine, School of Health Sciences, University of Iceland, Reykjavík, Iceland.
Vias RD; Department of Mathematics, Faculty of Physical Sciences, University of Iceland, Reykjavík, Iceland.
Lúðvíksson BR; Department of Medicine, School of Health Sciences, University of Iceland, Reykjavík, Iceland.; Department of Immunology, Landspítali University Hospital, Reykjavík, Iceland.
Brynjólfsson SF; Department of Medicine, School of Health Sciences, University of Iceland, Reykjavík, Iceland.; Department of Immunology, Landspítali University Hospital, Reykjavík, Iceland.
Gianchecchi E; VisMederi Srl, Siena, Italy.
Razzano I; VisMederi Srl, Siena, Italy.
Montomoli E; VisMederi Srl, Siena, Italy.; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Gísli Jónsson Ó; The Children's Hospital Iceland, Landspítali University Hospital, Reykjavík, Iceland.; Department of Medicine, School of Health Sciences, University of Iceland, Reykjavík, Iceland.
Haraldsson Á; The Children's Hospital Iceland, Landspítali University Hospital, Reykjavík, Iceland.; Department of Medicine, School of Health Sciences, University of Iceland, Reykjavík, Iceland.
Pokaż więcej
Źródło:
Acta paediatrica (Oslo, Norway : 1992) [Acta Paediatr] 2024 Mar; Vol. 113 (3), pp. 606-614. Date of Electronic Publication: 2023 Dec 23.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/drug therapy
Influenza, Human*/prevention & control
Influenza Vaccines*/therapeutic use
Leukemia*
Child ; Humans ; Male ; Streptococcus pneumoniae ; Vaccination ; Immunity ; Pneumococcal Vaccines/therapeutic use
Czasopismo naukowe
Tytuł:
Influenza B-induced longitudinally extensive transverse myelitis and bithalamic acute disseminated encephalomyelitis.
Autorzy:
Geurs N; Department of Neurology, Geel General Hospital, Ziekenhuis Netwerk Kempen, Ziekenhuis Geel, JB Stessenstraat 2, 2440, Geel, Belgium.; Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
Hoffbauer K; Department of Neurology, Geel General Hospital, Ziekenhuis Netwerk Kempen, Ziekenhuis Geel, JB Stessenstraat 2, 2440, Geel, Belgium.; Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
Belmans A; Department of Neuroradiology, Geel General Hospital, Ziekenhuis Netwerk Kempen, Geel, Belgium.
De Cauwer H; Department of Neurology, Geel General Hospital, Ziekenhuis Netwerk Kempen, Ziekenhuis Geel, JB Stessenstraat 2, 2440, Geel, Belgium. .; Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium. .
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2024 Mar; Vol. 45 (3), pp. 1299-1301. Date of Electronic Publication: 2023 Oct 17.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Myelitis, Transverse*/diagnostic imaging
Myelitis, Transverse*/etiology
Encephalomyelitis, Acute Disseminated*/complications
Encephalomyelitis, Acute Disseminated*/diagnostic imaging
Influenza, Human*/complications
Influenza, Human*/diagnostic imaging
Male ; Humans ; Adult ; Central Nervous System ; Spinal Puncture
Raport
Tytuł:
Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia.
Autorzy:
Lee CH; Department of Critical Care Medicine, University of Calgary, Alberta, Canada.
Banoei MM; Department of Critical Care Medicine, University of Calgary, Alberta, Canada.
Ansari M; Department of Critical Care Medicine, University of Calgary, Alberta, Canada.
Cheng MP; Divisions of Infectious Diseases & Medical Microbiology, McGill University Health Center, McGill's Interdisciplinary Initiative in Infection and Immunity, Montreal, PQ, Canada.
Lamontagne F; University of Sherbrooke, Sherbrooke, QC, Canada.
Griesdale D; Critical Care Medicine, Vancouver General Hospital and University of British Columbia, 2775 Laurel St, Vancouver, BC, V5Z 1M9, Canada.
Lasry DE; Divisions of Infectious Diseases & Medical Microbiology, McGill University Health Center, McGill's Interdisciplinary Initiative in Infection and Immunity, Montreal, PQ, Canada.
Demir K; Divisions of Infectious Diseases & Medical Microbiology, McGill University Health Center, McGill's Interdisciplinary Initiative in Infection and Immunity, Montreal, PQ, Canada.
Dhingra V; Critical Care Medicine, Vancouver General Hospital and University of British Columbia, 2775 Laurel St, Vancouver, BC, V5Z 1M9, Canada.
Tran KC; Division of General Internal Medicine, Vancouver General Hospital and University of British Columbia, 2775 Laurel St, Vancouver, BC, V5Z 1M9, Canada.
Lee T; Centre for Health Evaluation and Outcome Science (CHEOS), St. Paul's Hospital and University of British Columbia, 1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada.
Burns K; Department of Medicine, Division of Nephrology, Ottawa Hospital Research Institute, and University of Ottawa, 1967 Riverside Dr., Rm. 535, Ottawa, ON, K1H 7W9, Canada.
Sweet D; Critical Care Medicine and Emergency Medicine, Vancouver General Hospital and University of British Columbia, 2775 Laurel St, Vancouver, BC, V5Z 1M9, Canada.
Marshall J; Department of Surgery, St. Michael's Hospital and University of Toronto, 30 Bond Street, Toronto, ON, M5B 1W8, Canada.
Slutsky A; Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital; Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada.
Murthy S; British Columbia Children's Hospital, University of British Columbia, 4500 Oak Street, Vancouver, BC, V6H 3N1, Canada.
Singer J; Centre for Health Evaluation and Outcome Science (CHEOS), St. Paul's Hospital and University of British Columbia, 1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada.
Patrick DM; British Columbia Centre for Disease Control (BCCDC) and School of Population and Public Health, University of British Columbia, 655 West 12th Avenue, Vancouver, BC, V5Z 4R4, Canada.
Lee TC; Divisions of Infectious Diseases & Medical Microbiology, McGill University Health Center, McGill's Interdisciplinary Initiative in Infection and Immunity, Montreal, PQ, Canada.
Boyd JH; Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.; Division of Critical Care Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
Walley KR; Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.; Division of Critical Care Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
Fowler R; Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada.
Haljan G; Department of Medicine and Critical Care Medicine, Surrey Memorial Hospital, 13750 96th Avenue, Surrey, BC, V3V 1Z2, Canada.
Vinh DC; Divisions of Infectious Diseases & Medical Microbiology, McGill University Health Center, McGill's Interdisciplinary Initiative in Infection and Immunity, Montreal, PQ, Canada.
Mcgeer A; Mt. Sinai Hospital and University of Toronto, 600 University Avenue, Toronto, ON, M5G 1X5, Canada.
Maslove D; Department of Critical Care, Kingston General Hospital and Queen's University, 76 Stuart Street, Kingston, ON, K7L 2V7, Canada.
Mann P; Black Tusk, Vancouver, BC, Canada.
Donohoe K; Black Tusk, Vancouver, BC, Canada.
Hernandez G; Black Tusk, Vancouver, BC, Canada.
Rocheleau G; Black Tusk, Vancouver, BC, Canada.
Trahtemberg U; Department of Critical Care, Galilee Medical Center, Nahariya, Israel.; Bar Ilan University, Ramat Gan, Israel.; Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.
Kumar A; Departments of Medicine and Medical Microbiology, University of Manitoba, Winnipeg, Canada.
Lou M; Departments of Medicine and Medical Microbiology, University of Manitoba, Winnipeg, Canada.
Dos Santos C; Department of Medicine and Interdepartmental Division of Critical Care, University of Toronto, Toronto, Canada.
Baker A; Departments of Critical Care and Anesthesia, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
Russell JA; Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.; Division of Critical Care Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
Winston BW; Departments of Critical Care Medicine, Medicine and Biochemistry and Molecular Biology, University of Calgary, Health Research Innovation Center (HRIC), Room 4C64, 3280 Hospital Drive NW, Calgary, AB, T2N 4Z6, Canada. .
Pokaż więcej
Corporate Authors:
*ARBs CORONA I. Investigators
Źródło:
Critical care (London, England) [Crit Care] 2024 Feb 27; Vol. 28 (1), pp. 63. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/complications
Influenza, Human*/complications
Influenza, Human*/therapy
Influenza A Virus, H1N1 Subtype*
Respiratory Distress Syndrome*/complications
Respiratory Distress Syndrome*/therapy
Pneumonia, Bacterial*
Humans ; Tandem Mass Spectrometry ; Chromatography, Liquid ; Lysine ; Pyruvates
Czasopismo naukowe
Tytuł:
Healthcare-seeking behaviours of patients with acute respiratory infection: a cross-sectional survey in a rural area of southwest China.
Autorzy:
Dai P; Division of Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Qi L; Chongqing Municipal Center for Disease Control and Prevention, Chongqing, China.
Jia M; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Li T; Chongqing Municipal Center for Disease Control and Prevention, Chongqing, China.
Ran H; Wanzhou District Center for Disease Control and Prevention, Wanzhou District, Chongqing, China.
Jiang M; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Tang W; Chongqing Municipal Center for Disease Control and Prevention, Chongqing, China.
Yan C; Wanzhou District Center for Disease Control and Prevention, Wanzhou District, Chongqing, China.
Yang W; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Ren Y; Wanzhou District Center for Disease Control and Prevention, Wanzhou District, Chongqing, China .
Feng L; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China .
Pokaż więcej
Źródło:
BMJ open [BMJ Open] 2024 Feb 15; Vol. 14 (2), pp. e077224. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Influenza, Human*/therapy
Respiratory Tract Infections*/therapy
Respiratory Tract Infections*/drug therapy
Humans ; Cross-Sectional Studies ; Delivery of Health Care ; Patient Acceptance of Health Care ; China/epidemiology ; Health Facilities ; Tertiary Care Centers
Czasopismo naukowe
Tytuł:
Association between Statins Administration and Influenza Susceptibility: A Systematic Review and Meta-Analysis of Longitudinal Studies.
Autorzy:
Wu F; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Wang C; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Li S; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Ye Y; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Cui M; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Liu Y; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Jiang S; Nanshan District Center for Disease Control and Prevention, Shenzhen 518000, China.
Qian J; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Yuan J; Nanshan District Center for Disease Control and Prevention, Shenzhen 518000, China.
Shu Y; NHC Key Laboratory of System Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100730, China.
Sun C; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.; Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou 514400, China.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Feb 10; Vol. 16 (2). Date of Electronic Publication: 2024 Feb 10.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Aged ; Female ; Humans ; Middle Aged ; Longitudinal Studies
Czasopismo naukowe
Tytuł:
The effect of nonpharmaceutical interventions on influenza virus transmission.
Autorzy:
Chen D; School of Medical Technology and Informatlon Engineering, Zhejiang Chinese Medical University, Hangzhou, China.; Department of Laboratory Medicine, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou, China.
Zhang T; School of Medical Technology and Informatlon Engineering, Zhejiang Chinese Medical University, Hangzhou, China.
Chen S; Department of Laboratory Medicine, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou, China.
Ru X; Department of Laboratory Medicine, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou, China.
Shao Q; School of Medical Technology and Informatlon Engineering, Zhejiang Chinese Medical University, Hangzhou, China.; Department of Laboratory Medicine, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou, China.
Ye Q; Department of Laboratory Medicine, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou, China.
Cheng D; School of Medical Technology and Informatlon Engineering, Zhejiang Chinese Medical University, Hangzhou, China.
Pokaż więcej
Źródło:
Frontiers in public health [Front Public Health] 2024 Feb 08; Vol. 12, pp. 1336077. Date of Electronic Publication: 2024 Feb 08 (Print Publication: 2024).
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
COVID-19*/epidemiology
Orthomyxoviridae*
Humans ; Disease Outbreaks ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010-2020 surveillance-based study.
Autorzy:
García-Azorín D; Department of Neurology, Headache Unit, Hospital Clínico Universitario de Valladolid, Hospital Clínico Universitario de Valladolid, Rondilla Santa Teresa Streat S/N, Edificio Rondilla, 47010, Valladolid, Spain. .; Department of Medicine, Faculty of Medicine, Universidad de Valladolid, Hospital Clínico Universitario de Valladolid, Rondilla Santa Teresa Streat S/N, Edificio Rondilla, 47010, Valladolid, Spain. .
Santana-López L; Department of Neurology, Headache Unit, Hospital Clínico Universitario de Valladolid, Hospital Clínico Universitario de Valladolid, Rondilla Santa Teresa Streat S/N, Edificio Rondilla, 47010, Valladolid, Spain.
Lozano-Alonso JE; Fundación Instituto de Estudios de Ciencias de La Salud de Castilla y León, ICSCYL, Valladolid, Soria, Spain.
Ordax-Díez A; Fundación Instituto de Estudios de Ciencias de La Salud de Castilla y León, ICSCYL, Valladolid, Soria, Spain.
Vega-Alonso T; Dirección General de Salud Pública, Consejería de Sanidad, Junta de Castilla y León, Valladolid, Spain.
Macias Saint-Gerons D; Department of Medicine, University of Valencia; INCLIVA Health Research Institute and CIBERSAM, Valencia, Spain.
González-Osorio Y; Department of Neurology, Headache Unit, Hospital Clínico Universitario de Valladolid, Hospital Clínico Universitario de Valladolid, Rondilla Santa Teresa Streat S/N, Edificio Rondilla, 47010, Valladolid, Spain.
Rojo-Rello S; Department of Microbiology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Eiros JM; Department of Microbiology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.; National Influenza Centre, Valladolid, Spain.
Sánchez-Martínez J; National Influenza Centre, Valladolid, Spain.
Sierra-Mencía Á; Department of Neurology, Headache Unit, Hospital Clínico Universitario de Valladolid, Hospital Clínico Universitario de Valladolid, Rondilla Santa Teresa Streat S/N, Edificio Rondilla, 47010, Valladolid, Spain.
Recio-García A; Department of Neurology, Headache Unit, Hospital Clínico Universitario de Valladolid, Hospital Clínico Universitario de Valladolid, Rondilla Santa Teresa Streat S/N, Edificio Rondilla, 47010, Valladolid, Spain.
Martín-Toribio A; Fundación Instituto de Estudios de Ciencias de La Salud de Castilla y León, ICSCYL, Valladolid, Soria, Spain.; National Influenza Centre, Valladolid, Spain.
Sanz-Muñoz I; Department of Microbiology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.; National Influenza Centre, Valladolid, Spain.
Guerrero-Peral ÁL; Department of Neurology, Headache Unit, Hospital Clínico Universitario de Valladolid, Hospital Clínico Universitario de Valladolid, Rondilla Santa Teresa Streat S/N, Edificio Rondilla, 47010, Valladolid, Spain.; Department of Medicine, Faculty of Medicine, Universidad de Valladolid, Hospital Clínico Universitario de Valladolid, Rondilla Santa Teresa Streat S/N, Edificio Rondilla, 47010, Valladolid, Spain.
Pokaż więcej
Źródło:
The journal of headache and pain [J Headache Pain] 2024 Feb 08; Vol. 25 (1), pp. 18. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Influenza, Human*/complications
Influenza, Human*/epidemiology
Humans ; Female ; Headache/epidemiology ; Headache/etiology ; Prognosis ; Hospitalization ; Absenteeism
Czasopismo naukowe
Tytuł:
The respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus-associated disease in breakthrough infections in adults ≥60 years of age.
Autorzy:
Curran D; GSK Wavre Belgium.
Matthews S; Freelance c/o GSK Wavre Belgium.
Cabrera ES; GSK Wavre Belgium.
Pérez SN; CAP Centelles Barcelona Spain.
Breva LP; Vaccine Research FISABIO-Public Health Valencia Spain.
Rämet M; Finnish Vaccine Research Tampere Finland.
Helman L; Department of Clinical Medicine George Washington University School of Medicine & Health Sciences Washington District of Columbia USA.
Park DW; Korea University Ansan Hospital Ansan Republic of Korea.
Schwarz TF; Institute of Laboratory Medicine and Vaccination Centre Klinikum Würzburg Mitte Würzburg Germany.
Melendez IMG; Hospital Universitario Fundacion Alcorcon Madrid Spain.
Schaefer A; Medizentrum Essen Borbeck Essen Germany.
Roy N; Medicor Research Greater Sudbury Canada.
Stephan B; SGS proDERM Schenefeld Germany.
Molnar D; GSK Wavre Belgium.
Kostanyan L; GSK Wavre Belgium.
Powers JH 3rd; Department of Clinical Medicine George Washington University School of Medicine & Health Sciences Washington District of Columbia USA.
Hulstrøm V; GSK Wavre Belgium.
Pokaż więcej
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Feb 03; Vol. 18 (2), pp. e13236. Date of Electronic Publication: 2024 Feb 03 (Print Publication: 2024).
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Respiratory Syncytial Virus Vaccines*/therapeutic use
Respiratory Syncytial Virus Infections*/epidemiology
Respiratory Syncytial Virus Infections*/prevention & control
Respiratory Syncytial Virus, Human*
Respiratory Tract Infections*
Influenza, Human*/prevention & control
Influenza, Human*/drug therapy
Humans ; Aged ; Middle Aged ; Breakthrough Infections ; Viral Fusion Proteins ; Antibodies, Viral ; Antibodies, Neutralizing
Czasopismo naukowe
Tytuł:
An exploration of the value of NLR, PLR, LMR, and WBC × CRP for the diagnosis and treatment of influenza B in adults.
Autorzy:
Qi JF; Department of Clinical Laboratory, Xinchang Hospital of traditional Chinese (MD) Medicine, Shaoxing, Zhejiang Province, People's Republic of China.
Guo ML; Department of Clinical Laboratory, The People's Hospital of Cangnan Zhejiang, Wenzhou, Zhejiang Province, People's Republic of China.
Lin L; Department of Rehabilitation, Taizhou Hospital of Zhejiang Province, Taizhou, Zhejiang province, People's Republic of China.
Fu S; Department of Clinical Laboratory, Linping Campus, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang Province, People's Republic of China.
Chen LL; Department of Clinical Laboratory, Xinchang Hospital of traditional Chinese (MD) Medicine, Shaoxing, Zhejiang Province, People's Republic of China.
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2024 Feb 02; Vol. 103 (5), pp. e37046.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/diagnosis
Influenza, Human*/therapy
Adult ; Humans ; Bacterial Infections/diagnosis ; Bacterial Infections/therapy ; Lymphocytes ; Monocytes ; Neutrophils/metabolism ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
Autorzy:
Rose AMC; Epiconcept, Paris, France.
Pozo F; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Martínez-Baz I; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.
Mazagatos C; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.
Bossuyt N; Sciensano, Brussels, Belgium.
Cauchi JP; Department for Health Regulation, Health Promotion and Disease Prevention, Msida, Malta.
Petrović G; Croatian Institute of Public Health, Zagreb, Croatia.
Loghin II; St Parascheva Clinical Hospital of Infectious Diseases, Iasi, Romania.
Vaikutyte R; Lithuanian University of Health Sciences, Kaunas, Lithuania.
Buda S; Robert Koch Institute, Berlin, Germany.
Machado A; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
Duffy R; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
Oroszi B; Semmelweis University, Budapest, Hungary.
Howard J; Epiconcept, Paris, France.
Echeverria A; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.
Andreu C; Subdirección de Epidemiología, Dirección General de Salud Pública, Servicio Extremeño de Salud, Mérida, Spain.
Barbezange C; Sciensano, Brussels, Belgium.
Džiugytė A; Department for Health Regulation, Health Promotion and Disease Prevention, Msida, Malta.
Nonković D; Teaching Public Health Institute of Split-Dalmatia County, Split, Croatia.
Popescu CP; Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania.
Majauskaite F; Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania.
Tolksdorf K; Robert Koch Institute, Berlin, Germany.
Gomez V; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
Domegan L; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
Horváth JK; Semmelweis University, Budapest, Hungary.
Castilla J; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.
García M; Dirección General de Salud Pública, Departamento de Sanidad, Gobierno de Aragón, Zaragoza, Spain.
Demuyser T; Department of Microbiology and Infection control, UZ Brussel, Brussels, Belgium.
Borg ML; Department for Health Regulation, Health Promotion and Disease Prevention, Msida, Malta.
Tabain I; Croatian Institute of Public Health, Zagreb, Croatia.
Lazar M; 'Cantacuzino' National Military-Medical Institute for Research and Development, Bucharest, Romania.
Kubiliute I; Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania.
Dürrwald R; Robert Koch Institute, Berlin, Germany.
Guiomar R; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
O'Donnell J; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
Kristóf K; Semmelweis University, Budapest, Hungary.
Nicolay N; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Bacci S; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Kissling E; Epiconcept, Paris, France.
Pokaż więcej
Corporate Authors:
VEBIS SARI VE network team
Belgium SARI Surveillance Network (BelsariNet)
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Feb; Vol. 18 (2), pp. e13255.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza A Virus, H1N1 Subtype*/genetics
Influenza Vaccines*
Pneumonia*
Adult ; Humans ; Seasons ; Influenza A Virus, H3N2 Subtype/genetics ; Case-Control Studies ; Vaccine Efficacy ; Europe/epidemiology ; Hospitalization ; Hospitals ; Vaccination
Czasopismo naukowe
Tytuł:
Measuring waning protection from seasonal influenza vaccination during nine influenza seasons, Ontario, Canada, 2010/11 to 2018/19.
Autorzy:
Chung H; ICES, Toronto, Canada.
Campitelli MA; ICES, Toronto, Canada.
Buchan SA; Public Health Ontario, Toronto, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.; ICES, Toronto, Canada.
Campigotto A; London Health Sciences Centre, London, Canada.; Hospital for Sick Children, Toronto, Canada.
Crowcroft NS; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Canada.; Public Health Ontario, Toronto, Canada.; ICES, Toronto, Canada.
Gubbay JB; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.; Hospital for Sick Children, Toronto, Canada.; Public Health Ontario, Toronto, Canada.
Jung JK; ICES, Toronto, Canada.
Karnauchow T; Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada.; Children's Hospital of Eastern Ontario, Ottawa, Canada.
Katz K; North York General Hospital, Toronto, Canada.
McGeer AJ; Sinai Health System, Toronto, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
McNally JD; Children's Hospital of Eastern Ontario, Ottawa, Canada.
Richardson DC; William Osler Health System, Brampton, Canada.
Richardson SE; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.; Hospital for Sick Children, Toronto, Canada.
Rosella LC; Public Health Ontario, Toronto, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.; ICES, Toronto, Canada.
Russell ML; Cumming School of Medicine, University of Calgary, Calgary, Canada.
Schwartz KL; Public Health Ontario, Toronto, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.; ICES, Toronto, Canada.
Simor A; Sunnybrook Health Sciences Centre, Toronto, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
Smieja M; McMaster University, Hamilton, Canada.
Sundaram ME; Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Marshfield, United States.; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.; ICES, Toronto, Canada.
Warshawsky BF; Western University, London, Canada.; Public Health Ontario, Toronto, Canada.
Zahariadis G; Newfoundland and Labrador Public Health Laboratory, St. John's, Canada.; London Health Sciences Centre, London, Canada.
Kwong JC; ICES, Toronto, Canada.; Department of Family and Community Medicine, University of Toronto, Toronto, Canada.; University Health Network, Toronto, Canada.; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Canada.; Public Health Ontario, Toronto, Canada.
Pokaż więcej
Corporate Authors:
Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators; https://cirnetwork.ca/network/provincial-collaborative-network.
Źródło:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Feb; Vol. 29 (8).
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza Vaccines*
Influenza A Virus, H1N1 Subtype*
Humans ; Seasons ; Ontario/epidemiology ; Influenza A Virus, H3N2 Subtype ; Vaccination
Czasopismo naukowe
Tytuł:
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.
Autorzy:
Maurel M; Epiconcept, Paris, France.
Howard J; Epiconcept, Paris, France.
Kissling E; Epiconcept, Paris, France.
Pozo F; CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain.; National Centre for Microbiology, National Influenza Reference Laboratory, WHO-National Influenza Centre, Institute of Health Carlos III, Madrid, Spain.
Pérez-Gimeno G; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
Buda S; Department for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany.
Sève N; Sorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.
McKenna A; HSE Health Protection Surveillance Centre, Dublin, Ireland.
Meijer A; National Institute for Public Health and the Environment, Centre for Infectious Diseases Control, Bilthoven, the Netherlands.
Rodrigues AP; Epidemiology Department, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal.
Martínez-Baz I; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain.
Mlinarić I; Croatian Institute of Public Health, Zagreb, Croatia.
Latorre-Margalef N; Public Health Agency of Sweden, Stockholm, Sweden.
Túri G; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary.
Lazăr M; Cantacuzino National Military Medical Institute for Research and Development, Bucharest, Romania.
Mazagatos C; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
Echeverria A; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain.
Abela S; Infectious Disease Prevention and Control Unit (IDCU), Health Promotion and Disease Prevention, Msida, Malta.
Bourgeois M; Department of Infectious Diseases, CHU UCL Namur (site Godinne), Université catholique de Louvain, Yvoir, Belgium.
Machado A; Epidemiology Department, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal.
Dürrwald R; National Reference Centre for Influenza, Robert Koch Institute, Berlin, Germany.
Petrović G; Croatian Institute of Public Health, Zagreb, Croatia.
Oroszi B; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary.
Jancoriene L; Clinic of Infectious Diseases and Dermatovenerology, Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania.
Marin A; Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania.
Husa P; University Hospital Brno and Masaryk University, Brno, Czechia.
Duffy R; HSE Health Protection Surveillance Centre, Dublin, Ireland.
Dijkstra F; National Institute for Public Health and the Environment, Centre for Infectious Diseases Control, Bilthoven, the Netherlands.
Gallardo García V; Servicio de Vigilancia y Salud Laboral, Dirección General de Salud Pública y Ordenación Farmacéutica, Consejería de Salud y Consumo, Andalucía, Spain.
Goerlitz L; Department for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany.
Enouf V; Centre National de Référence Virus des Infections Respiratoire (CNR VIR), Institut Pasteur Université Paris Cité, Paris, France.
Bennett C; National Virus Reference Laboratory, University College Dublin, Dublin, Ireland.
Hooiveld M; Nivel, Utrecht, the Netherlands.
Guiomar R; Laboratório Nacional Referência Gripe e outros Vírus Respiratórios, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal.
Trobajo-Sanmartín C; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain.
Višekruna Vučina V; Croatian Institute of Public Health, Zagreb, Croatia.
Samuelsson Hagey T; Public Health Agency of Sweden, Stockholm, Sweden.
Lameiras Azevedo AS; Servicio de vigilancia y control epidemiológico, Subdirección general de Epidemiología y Vigilancia de la Salud, Dirección General de Salud pública, Valencia, Spain.
Castilla J; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain.
Xuereb G; Department of Child and Adolescent Health, Mater Dei Hospital, Msida, Malta.; Infectious Disease Prevention and Control Unit (IDCU), Health Promotion and Disease Prevention, Msida, Malta.
Delaere B; Department of Infectious Diseases, CHU UCL Namur (site Godinne), Université catholique de Louvain, Yvoir, Belgium.
Gómez V; Epidemiology Department, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal.
Tolksdorf K; Department for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany.
Bacci S; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Nicolay N; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Kaczmarek M; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Rose AM; Epiconcept, Paris, France.
Pokaż więcej
Corporate Authors:
European IVE group; The members of the European IVE group are listed under Acknowledgements.
Źródło:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Feb; Vol. 29 (8).
Typ publikacji:
Journal Article
MeSH Terms:
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza A Virus, H1N1 Subtype*
Humans ; Influenza B virus ; Influenza A Virus, H3N2 Subtype ; Vaccination ; Case-Control Studies ; Seasons ; Hospitals ; Primary Health Care
Czasopismo naukowe
Tytuł:
2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN).
Autorzy:
Skowronski DM; British Columbia Centre for Disease Control, Vancouver, Canada.; University of British Columbia, Vancouver, Canada.
Zhan Y; British Columbia Centre for Disease Control, Vancouver, Canada.
Kaweski SE; British Columbia Centre for Disease Control, Vancouver, Canada.
Sabaiduc S; British Columbia Centre for Disease Control, Vancouver, Canada.
Khalid A; British Columbia Centre for Disease Control, Vancouver, Canada.
Olsha R; Public Health Ontario, Toronto, Canada.
Carazo S; Institut National de Santé Publique du Québec, Québec, Canada.
Dickinson JA; University of Calgary, Calgary, Canada.
Mather RG; Public Health Ontario, Toronto, Canada.; Queen's University, Kingston, Canada.
Charest H; Institut National de Santé Publique du Québec, Québec, Canada.
Jassem AN; British Columbia Centre for Disease Control, Vancouver, Canada.
Levade I; Institut National de Santé Publique du Québec, Québec, Canada.
Hasso M; Public Health Ontario, Toronto, Canada.
Zelyas N; Public Health Laboratory, Alberta Precision Laboratories, Edmonton, Canada.
Gao R; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
Bastien N; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
Pokaż więcej
Źródło:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Feb; Vol. 29 (7).
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
COVID-19*
Humans ; Seasons ; Influenza A Virus, H3N2 Subtype/genetics ; Vaccine Efficacy ; Canada/epidemiology ; Sentinel Surveillance ; Vaccination ; Case-Control Studies
Czasopismo naukowe
Tytuł:
Impact of the COVID-19 related border restrictions on influenza and other common respiratory viral infections in New Zealand.
Autorzy:
Huang QS; Institute of Environmental Science and Research, Wellington, New Zealand.
Turner N; University of Auckland, Auckland, New Zealand.
Wood T; Institute of Environmental Science and Research, Wellington, New Zealand.
Anglemyer A; Institute of Environmental Science and Research, Wellington, New Zealand.; University of Otago, Dunedin, New Zealand.
McIntyre P; University of Otago, Dunedin, New Zealand.
Aminisani N; Institute of Environmental Science and Research, Wellington, New Zealand.
Dowell T; University of Otago, Dunedin, New Zealand.
Trenholme A; Te Whatu Ora, Health New Zealand Counties Manukau, Auckland, New Zealand.
Byrnes C; Te Whatu Ora, Health New Zealand Te Toka Tumai Auckland, Auckland, New Zealand.
Balm M; Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
McIntosh C; Te Whatu Ora, Health New Zealand Counties Manukau, Auckland, New Zealand.
Jefferies S; Institute of Environmental Science and Research, Wellington, New Zealand.
Grant CC; University of Auckland, Auckland, New Zealand.; Te Whatu Ora, Health New Zealand Te Toka Tumai Auckland, Auckland, New Zealand.
Nesdale A; Regional Public Health, Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
Dobinson HC; Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
Campbell-Stokes P; Regional Public Health, Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
Daniells K; Institute of Environmental Science and Research, Wellington, New Zealand.
Geoghegan J; Institute of Environmental Science and Research, Wellington, New Zealand.; University of Otago, Dunedin, New Zealand.
de Ligt J; Institute of Environmental Science and Research, Wellington, New Zealand.
Jelley L; Institute of Environmental Science and Research, Wellington, New Zealand.; University of Otago, Dunedin, New Zealand.
Seeds R; Institute of Environmental Science and Research, Wellington, New Zealand.
Jennings T; Regional Public Health, Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
Rensburg M; Regional Public Health, Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
Cueto J; Regional Public Health, Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
Caballero E; Regional Public Health, Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
John J; Regional Public Health, Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
Penghulan E; Regional Public Health, Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
Tan CE; Institute of Environmental Science and Research, Wellington, New Zealand.
Ren X; Institute of Environmental Science and Research, Wellington, New Zealand.
Berquist K; Institute of Environmental Science and Research, Wellington, New Zealand.
O'Neill M; Institute of Environmental Science and Research, Wellington, New Zealand.
Marull M; Institute of Environmental Science and Research, Wellington, New Zealand.
Yu C; Institute of Environmental Science and Research, Wellington, New Zealand.
McNeill A; Institute of Environmental Science and Research, Wellington, New Zealand.
Kiedrzynski T; Te Pou Hauora Tūmatanui, the Public Health Agency, Manatū Hauora, Ministry of Health, Wellington, New Zealand.
Roberts S; Te Whatu Ora, Health New Zealand Te Toka Tumai Auckland, Auckland, New Zealand.
McArthur C; Te Whatu Ora, Health New Zealand Te Toka Tumai Auckland, Auckland, New Zealand.
Stanley A; Te Whatu Ora, Health New Zealand Te Toka Tumai Auckland, Auckland, New Zealand.
Taylor S; Te Whatu Ora, Health New Zealand Counties Manukau, Auckland, New Zealand.
Wong C; Te Whatu Ora, Health New Zealand Counties Manukau, Auckland, New Zealand.
Lawrence S; Te Whatu Ora, Health New Zealand Counties Manukau, Auckland, New Zealand.
Baker MG; University of Otago, Dunedin, New Zealand.
Kvalsvig A; University of Otago, Dunedin, New Zealand.
Van Der Werff K; Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
McAuliffe G; Te Whatu Ora, Health New Zealand Te Toka Tumai Auckland, Auckland, New Zealand.
Antoszewska H; Te Whatu Ora, Health New Zealand Te Toka Tumai Auckland, Auckland, New Zealand.
Dilcher M; Te Whatu Ora, Health New Zealand Waitaha Canterbury, Christchurch, New Zealand.
Fahey J; Te Whatu Ora, Health New Zealand Waitaha Canterbury, Christchurch, New Zealand.
Werno A; Te Whatu Ora, Health New Zealand Waitaha Canterbury, Christchurch, New Zealand.
Elvy J; Southern Community Laboratories, Dunedin, New Zealand.
Grant J; Southern Community Laboratories, Dunedin, New Zealand.
Addidle M; Te Whatu Ora, Health New Zealand Hauora a Toi Bay of Plenty, Tauranga, New Zealand.
Zacchi N; Te Whatu Ora, Health New Zealand Hauora a Toi Bay of Plenty, Tauranga, New Zealand.
Mansell C; Te Whatu Ora, Health New Zealand Waikato, Hamilton, New Zealand.
Widdowson MA; Institute of Tropical Medicine, Antwerp, Belgium.
Thomas PG; WHO Collaborating Centre, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Webby RJ; WHO Collaborating Centre, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Pokaż więcej
Corporate Authors:
BorderRestrictionImpactOnFluRSV Consortium; Institute of Environmental Science and Research, Wellington, New Zealand.; Te Whatu Ora, Health New Zealand Counties Manukau, Auckland, New Zealand.; Te Whatu Ora, Health New Zealand Te Toka Tumai Auckland, Auckland, New Zealand.; Regional Public Health, Te Whatu Ora, Health New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.; Te Whatu Ora, Health New Zealand Waitaha Canterbury, Christchurch, New Zealand.
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Feb; Vol. 18 (2), pp. e13247.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
COVID-19*/epidemiology
COVID-19*/prevention & control
Respiratory Tract Infections*/epidemiology
Respiratory Tract Infections*/prevention & control
Respiratory Syncytial Virus Infections*/epidemiology
Virus Diseases*
Respiratory Syncytial Virus, Human*
Humans ; New Zealand/epidemiology
Czasopismo naukowe
Tytuł:
Respiratory Syncytial Virus and influenza infections in adults: more in common than meets the eye.
Autorzy:
Leonardo RO; Consejero científico y Director Emérito del National Influenza Center de Valladolid, Valladolid, Spain. Electronic address: .
Pokaż więcej
Źródło:
Enfermedades infecciosas y microbiologia clinica (English ed.) [Enferm Infecc Microbiol Clin (Engl Ed)] 2024 Feb; Vol. 42 (2), pp. 59-61.
Typ publikacji:
Editorial
MeSH Terms:
Influenza, Human*/complications
Influenza, Human*/epidemiology
Respiratory Syncytial Virus, Human*
Respiratory Syncytial Virus Infections*/complications
Respiratory Syncytial Virus Infections*/epidemiology
Adult ; Humans
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies